BRIDGE PHARMA - Trademark Details
Status: 680 - Approved For Publication
Serial Number
97978608
Word Mark
BRIDGE PHARMA
Status
680 - Approved For Publication
Status Date
2024-08-07
Filing Date
2023-01-18
Mark Drawing
4 - Standard character mark
Attorney Name
Law Office Assigned Location Code
L20
Employee Name
KIDWELL WALKER, JACLYN
Statements
Disclaimer
"PHARMA"
Goods and Services
Pharmaceutical products for use by humans, namely, sterile injectable pharmaceutical preparations for the treatment of dehydration, low potassium levels, bleeding, infection, and pain
Goods and Services
Custom manufacture of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2023-01-25
Primary Code
005
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2023-01-25
Primary Code
040
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Lisel M. Ferguson PROCOPIO CORY HARGREAVES & SAVITCH LLP
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2023-01-21 | NEW APPLICATION ENTERED |
| 2023-01-25 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 2023-10-16 | ASSIGNED TO EXAMINER |
| 2023-10-25 | NON-FINAL ACTION WRITTEN |
| 2023-10-25 | NON-FINAL ACTION E-MAILED |
| 2023-10-25 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2024-01-24 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2024-01-24 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2024-01-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2024-03-07 | FINAL REFUSAL WRITTEN |
| 2024-03-07 | FINAL REFUSAL E-MAILED |
| 2024-03-07 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2024-05-14 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2024-06-07 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 2024-06-07 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 2024-08-06 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2024-05-14 | DIVISIONAL REQUEST RECEIVED |
| 2024-08-07 | DIVISIONAL PROCESSING COMPLETE |
| 2024-08-07 | APPROVED FOR PUB - PRINCIPAL REGISTER |
